182 related articles for article (PubMed ID: 28616661)
21. Increased expression of IL-28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Cheng YY; Sheng YJ; Chang Y; Lin Y; Zhu ZW; Wen LL; Yang C; Liu L; Yang LL; Zhou FS; Zheng XD; Yin XY; Zhang SQ; Cui Y; Yang S; Zhang XJ
Clin Rheumatol; 2015 Oct; 34(10):1807-11. PubMed ID: 25911176
[TBL] [Abstract][Full Text] [Related]
22. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.
Devilliers H; Bonithon-Kopp C; Jolly M
Lupus; 2017 Apr; 26(4):396-402. PubMed ID: 27587460
[TBL] [Abstract][Full Text] [Related]
23. The elevation of plasma DNA in patients with systemic lupus erythematosus is attributable to increased DNA release and defective DNA binding of mononuclear cells.
Tsai CY; Yu CL; Huang DF; Hsieh SC; Tsai YY; Tsai ST
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):291-9. PubMed ID: 7834551
[TBL] [Abstract][Full Text] [Related]
24. Late-onset systemic lupus erythematosus: Is it "mild lupus"?
Sohn IW; Joo YB; Won S; Bae SC
Lupus; 2018 Feb; 27(2):235-242. PubMed ID: 28650278
[TBL] [Abstract][Full Text] [Related]
25. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Liu C; Chen X; Jin Y; Qu R; Jiang PF; Wen GM; Tang ZH
Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
27. Expression of reversion-inducing cysteine-rich protein with Kazal motifs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus: links to disease activity, damage accrual and matrix metalloproteinase 9 secretion.
Hou C; Zhang Y
J Int Med Res; 2008; 36(4):704-13. PubMed ID: 18652766
[TBL] [Abstract][Full Text] [Related]
28. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
29. TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients.
El-Karaksy SM; Kholoussi NM; Shahin RM; El-Ghar MM; Gheith Rel-S
Gene; 2013 Sep; 527(1):211-4. PubMed ID: 23792015
[TBL] [Abstract][Full Text] [Related]
30. Decreased ex vivo production of interferon-gamma is associated with severity and poor prognosis in patients with lupus.
Ahn SS; Park ES; Shim JS; Ha SJ; Kim BS; Jung SM; Lee SW; Park YB; Song JJ
Arthritis Res Ther; 2017 Aug; 19(1):193. PubMed ID: 28841837
[TBL] [Abstract][Full Text] [Related]
31. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
32. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
Islam MN; Hossain M; Haq SA; Alam MN; Ten Klooster PM; Rasker JJ
Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
[TBL] [Abstract][Full Text] [Related]
34. [Clinico-biological issues of systemic lupus erythematosus patients].
Belibou IC; Ancuţa C; Miu S; Ancuţa E; Păstrăguş C; Chirieac R
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):83-9. PubMed ID: 23077877
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the impairment of the uptake of apoptotic polymorphonuclear cells by monocyte subpopulations in systemic lupus erythematosus.
Mikołajczyk TP; Skiba D; Batko B; Krezelok M; Wilk G; Osmenda G; Pryjma JR; Guzik TJ
Lupus; 2014 Nov; 23(13):1358-69. PubMed ID: 24969081
[TBL] [Abstract][Full Text] [Related]
36. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
[TBL] [Abstract][Full Text] [Related]
37. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
Ren Y; Tang J; Mok MY; Chan AW; Wu A; Lau CS
Arthritis Rheum; 2003 Oct; 48(10):2888-97. PubMed ID: 14558095
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
39. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
[TBL] [Abstract][Full Text] [Related]
40. PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus.
Luo Q; Huang Z; Ye J; Deng Y; Fang L; Li X; Guo Y; Jiang H; Ju B; Huang Q; Li J
Arthritis Res Ther; 2016 Feb; 18():47. PubMed ID: 26867643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
